Clinical Trial Update: Multicenter Validation of the Sensitivity of Theranostic ALK Rearrangement Detection by FISH Analysis and Prevalence of Escaping Mutations in Circulating Tumor Cells for the Non-invasive Management of Lung Cancer Patients [NA]

View source ↗

Summary

A multicenter study validating the sensitivity of FISH for ALK rearrangements and assessing the prevalence of escaping mutations in circulating tumor cells for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Lung Neoplasms | NA | Status: COMPLETED